Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA

Brinton, E. A., Eckel, R. H., Gaudet, D., Ballantyne, C. M., Baker, B. F., Ginsberg, H. N., & Witztum, J. L. (2025). Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA. Atherosclerosis, 403, 119114. https://doi.org/10.1016/j.atherosclerosis.2025.119114
Authors:
Eliot A Brinton
Robert H Eckel
Daniel Gaudet
Christie M Ballantyne
Brenda F Baker
Henry N Ginsberg
Joseph L Witztum
Affiliated Authors:
Henry N Ginsberg
Columbia Affiliation:
Author Keywords:
antisense oligonucleotide
familial chylomicronemia syndrome
hepatic targeting therapies
hypertriglyceridemia
rna therapies
small interfering rna
elink
Publication Type:
Article
Unique ID:
10.1016/j.atherosclerosis.2025.119114
PMID:
40068508
DOI:
10.1016/j.atherosclerosis.2025.119114
Journal:
Atherosclerosis
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: